{"id":"https://openalex.org/W2965060554","doi":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","title":"STRUCTURAL VERIFICATION, MOLECULAR DOCKING AND ANTIPROLIFERATIVE ACTIVITY FOR AMINO ACETYLENIC OXY QUINOXALINES","display_name":"STRUCTURAL VERIFICATION, MOLECULAR DOCKING AND ANTIPROLIFERATIVE ACTIVITY FOR AMINO ACETYLENIC OXY QUINOXALINES","publication_year":2019,"publication_date":"2019-07-31","ids":{"openalex":"https://openalex.org/W2965060554","doi":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","mag":"2965060554"},"language":"en","primary_location":{"id":"doi:10.22376/ijpbs/lpr.2019.9.3.p1-12","doi":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","is_oa":true,"landing_page_url":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","pdf_url":null,"source":{"id":"https://openalex.org/S4210204561","display_name":"International Journal of Life Science and Pharma Research","issn_l":"2250-0480","issn":["2250-0480"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Life Science and Pharma Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067404930","display_name":"Zuhair A. Muhi-Eldeen","orcid":"https://orcid.org/0000-0003-0911-3397","observed_orcids":["https://orcid.org/0000-0003-0911-3397"]},"institutions":[{"id":"https://openalex.org/I36622005","display_name":"Petra University","ror":"https://ror.org/039d9es10","country_code":"JO","type":"education","lineage":["https://openalex.org/I36622005"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"ZUHAIR A MUHI-ELDEEN","raw_affiliation_strings":["Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, University of Petra, Amman, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, University of Petra, Amman, Jordan","institution_ids":["https://openalex.org/I36622005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014964343","display_name":"BAKR S MUSTAFA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36622005","display_name":"Petra University","ror":"https://ror.org/039d9es10","country_code":"JO","type":"education","lineage":["https://openalex.org/I36622005"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"BAKR S MUSTAFA","raw_affiliation_strings":["Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, University of Petra, Amman, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, University of Petra, Amman, Jordan","institution_ids":["https://openalex.org/I36622005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113825733","display_name":"Elham N. Al-Kaissi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36622005","display_name":"Petra University","ror":"https://ror.org/039d9es10","country_code":"JO","type":"education","lineage":["https://openalex.org/I36622005"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"ELHAM N AL-KAISSI","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Petra, Amman, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Petra, Amman, Jordan","institution_ids":["https://openalex.org/I36622005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035841002","display_name":"Mohammad A. Ghattas","orcid":"https://orcid.org/0000-0002-2240-8037","observed_orcids":["https://orcid.org/0000-0002-2240-8037"]},"institutions":[{"id":"https://openalex.org/I161913731","display_name":"Al Ain University","ror":"https://ror.org/023abrt21","country_code":"AE","type":"education","lineage":["https://openalex.org/I161913731"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"MOHAMMAD A GHATTAS","raw_affiliation_strings":["College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates","institution_ids":["https://openalex.org/I161913731"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.035999998450279236,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.026200000196695328,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.906000018119812},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7369999885559082},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7279999852180481},{"id":"https://openalex.org/keywords/structure-confirmation","display_name":"structure confirmation","score":0.7319999933242798},{"id":"https://openalex.org/keywords/kinase-inhibition","display_name":"kinase inhibition","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6326366066932678},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5762073397636414},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5278204083442688},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5223382711410522},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5195522904396057},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4952198565006256},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.4821712374687195},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4131927192211151},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4126436412334442},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.41186583042144775},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4047054946422577},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3101540207862854},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2731894850730896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16907146573066711},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.22376/ijpbs/lpr.2019.9.3.p1-12","doi":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","is_oa":true,"landing_page_url":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","pdf_url":null,"source":{"id":"https://openalex.org/S4210204561","display_name":"International Journal of Life Science and Pharma Research","issn_l":"2250-0480","issn":["2250-0480"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Life Science and Pharma Research","raw_type":"journal-article"},{"id":"pmh:oai:ojs2.ijlpr.com:article/807","doi":null,"is_oa":true,"landing_page_url":"https://www.ijlpr.com/index.php/journal/article/view/807","pdf_url":"https://www.ijlpr.com/index.php/journal/article/download/807/633","source":{"id":"https://openalex.org/S4210204561","display_name":"International Journal of Life Science and Pharma Research","issn_l":"2250-0480","issn":["2250-0480"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2250-0480","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.22376/ijpbs/lpr.2019.9.3.p1-12","doi":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","is_oa":true,"landing_page_url":"https://doi.org/10.22376/ijpbs/lpr.2019.9.3.p1-12","pdf_url":null,"source":{"id":"https://openalex.org/S4210204561","display_name":"International Journal of Life Science and Pharma Research","issn_l":"2250-0480","issn":["2250-0480"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Life Science and Pharma Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319684","display_name":"University of Petra","ror":"https://ror.org/039d9es10"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2965060554.pdf","grobid_xml":"https://content.openalex.org/works/W2965060554.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W255996521","https://openalex.org/W1994928998","https://openalex.org/W2000073530","https://openalex.org/W2031168104","https://openalex.org/W2043103956","https://openalex.org/W2059317968","https://openalex.org/W2102377211","https://openalex.org/W2105668062","https://openalex.org/W2110444464","https://openalex.org/W2128307445","https://openalex.org/W2134630203","https://openalex.org/W2158534713","https://openalex.org/W2162525969","https://openalex.org/W2166056968","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7220615666","https://openalex.org/W2415664107","https://openalex.org/W4317627136","https://openalex.org/W4220812349","https://openalex.org/W3211021531","https://openalex.org/W2152081474","https://openalex.org/W2148685331","https://openalex.org/W297521948","https://openalex.org/W2073819753","https://openalex.org/W4401332817"],"abstract_inverted_index":{"Tyrosine":[0,50],"kinase":[1,18,51,109],"inhibitors":[2,110],"of":[3,11,56,62,71,89,145,168],"the":[4,54,69,164,189],"epidermal":[5,91,100],"growth":[6,92,101],"factor":[7,93,102],"receptor":[8,94,103],"(EGFR)":[9],"are":[10,20],"interest":[12],"to":[13,68,126,187,193],"drug":[14,24,73],"companies.":[15],"These":[16,170],"proteins":[17,28],"(PKs)":[19],"considered":[21],"as":[22],"validated":[23],"targets.":[25],"In":[26],"cancer,":[27],"kinases":[29,79],"play":[30],"a":[31,113,158],"key":[32,63],"role":[33],"in":[34,117,153,163],"regulating":[35],"numerous":[36],"cellular":[37,72],"functions":[38],"including":[39],"increased":[40,44],"proliferation,":[41],"decreased":[42],"apoptosis,":[43],"invasion,":[45],"metastasis,":[46],"and":[47,76,99,141,160,166,177],"promote":[48],"angiogenesis.":[49],"overproduction":[52],"inhibits":[53],"activity":[55,179,191],"various":[57],"anticancer":[58],"agents":[59],"via":[60],"suppression":[61],"apoptotic":[64],"mechanisms":[65],"thereby":[66],"leading":[67,192],"development":[70],"resistance.":[74],"Targeting":[75],"inhibiting":[77],"these":[78],"enzymes":[80],"became":[81],"attractive":[82],"candidates":[83],"for":[84],"cancer":[85,118,194],"therapy.":[86,119],"The":[87,120,143],"targeting":[88],"human":[90],"2":[95],"(HER2":[96],"or":[97,105,133],"ErB-2/neu)":[98],"(EGFR":[104,132],"HER1/ErB1)":[106],"by":[107,174],"tyrosine":[108],"(TKIs)":[111],"represent":[112],"promising":[114],"therapeutic":[115],"approach":[116,162],"new":[121,161],"novel":[122,159],"2-":[123],"[4-(t-amino-1-yl)but-2-yn1-yl]quinoxaline":[124],"(ZB-2":[125],"ZB-8),":[127],"provide":[128],"effective":[129,183],"overlap":[130,184],"with":[131,150,185],"HER2)":[134],"through":[135],"ionic,":[136],"hydrogen":[137],"bonding,":[138],"charge":[139],"transfer":[140],"hydrophobicity.":[142],"introduction":[144],"different":[146],"basic":[147],"amino":[148],"moiety":[149],"acetylenic":[151],"group":[152],"signal":[154],"transduction":[155],"inhibitor":[156],"represents":[157],"management":[165],"treatment":[167],"cancer.":[169],"speculations":[171],"were":[172],"supported":[173],"molecular":[175],"docking":[176],"pharmacological":[178],"which":[180],"shows":[181],"an":[182],"EGFR":[186],"initiate":[188],"inhibition":[190],"treatment.":[195]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-08-13T00:00:00"}